TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18088035

Group type: EXPERIMENTAL
Intervention: Continuous physical training (4 to 5 times weekly for 6 months)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No regular physical training
Number of subjects: 48
Study: 15571617

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 36

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 36
Study: 12206448

Group type: EXPERIMENTAL
Intervention: Bupropion SR 300 mg/day (150 mg b.i.d.)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 9405728

Group type: EXPERIMENTAL
Intervention: GnRH agonist treatment for 6 months
Number of subjects: 28
Study: 8949572

Group type: EXPERIMENTAL
Intervention: Intravenous GH infusion (0.03 microgram (0.1 mU/kg/min) for 39 hours)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Subcutaneous GH infusion (0.03 microgram (0.1 mU/kg/min) for 39 hours)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Intravenous GH infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Subcutaneous GH infusion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: GH administration (both routes)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both routes of GH administration
Number of subjects: 10
Study: 1672803

Group type: EXPERIMENTAL
Intervention: atracurium 0.6 mg.kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: vecuronium 0.1 mg.kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: half‐dose combinations of atracurium and vecuronium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: quarter‐dose combinations of atracurium and vecuronium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: full‐dose combinations of atracurium and vecuronium
Number of subjects: 30
Study: 7043395

Group type: EXPERIMENTAL
Intervention: Piribedil (0.1 mg/kg over 30 minutes)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Domperidone (prior administration)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (subjects free from headache)
Number of subjects: 40
Study: 30281094

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 14
Study: 27887967

Group type: EXPERIMENTAL
Intervention: Image-guided percutaneous nerve cryoablation
Number of subjects: 21
Study: 27716691

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 1 mcg/kg IV over 20 min followed by 0.5 mcg/kg/h for 72 h postoperative
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Amiodarone 5 mg/kg IV over 20 min followed by 10-15 mcg/kg/h for 72 h postoperative
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline IV
Number of subjects: 90
Study: 24760465

Group type: EXPERIMENTAL
Intervention: Ultrasound scissors
Number of subjects: 41

Group type: COMPARATOR
Intervention: Monopolar electrosurgery
Number of subjects: 41
Study: 21997455

Group type: EXPERIMENTAL
Intervention: Proprioceptive training program (30 minutes, 3 times a week for 6 weeks) including 5 exercises with the BOSU and Swiss ball.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned).
Number of subjects: 33
Study: 19229114

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt (300 g/day for 6 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ordinary yogurt (300 g/day for 6 weeks)
Number of subjects: 14
Study: 17218125

Group type: EXPERIMENTAL
Intervention: Thyroid collars (TCs) during radiography
Number of subjects: 200

Group type: COMPARATOR
Intervention: No thyroid collars (non-TC group)
Number of subjects: 200
Study: 15359221

Group type: EXPERIMENTAL
Intervention: Guided Imagery with Progressive Muscle Relaxation (GI with PMR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 28
Study: 11261907

Group type: EXPERIMENTAL
Intervention: Ketamine 0.3 mg/kg and 2% lignocaine infiltration
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ketamine 0.9 mg/kg and diazepam 0.07 mg/kg
Number of subjects: 50
Study: 9651414

Group type: EXPERIMENTAL
Intervention: Combined intervention (CI)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Pharmacologic-only intervention (PO)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Cross-sectional control group
Number of subjects: 92
Study: 7735519

Group type: EXPERIMENTAL
Intervention: Olea europaea pollen extract (immunotherapy)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 1684178

Group type: EXPERIMENTAL
Intervention: Broxaterol patch (size = 1.75 cm2; programmed delivery = 105 mcg/h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 10
Study: 6819891

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) with constant infusion of hypertonic glucose and amino acids by central vein (35 kcal/kg/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 50
Study: 29189585

Group type: EXPERIMENTAL
Intervention: Repeated-sprint running with deceleration (TMd)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Repeated-sprint running without deceleration (TMa)
Number of subjects: 14
Study: 30230658

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up for Toddlers (ABC‐T)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 88
Study: 28654155

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D (CaD) supplementation
Number of subjects: 34763

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34763
Study: 25723973

Group type: EXPERIMENTAL
Intervention: Dietary intervention with breastfeeding support
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Dietary intervention without breastfeeding support
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wait-list control group (dietary intervention issued at three months postpartum)
Number of subjects: 36
Study: 23863050

Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg IV, six injections every 4 weeks)
Number of subjects: 921

Group type: COMPARATOR
Intervention: Placebo (matching injections every 4 weeks)
Number of subjects: 921
Study: 22101697

Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC), 3 capsules, thrice a day for 30 days (2 courses)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Fengshi gutong capsule (FSGTC), 4 capsules, twice a day for 30 days (2 courses)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Xinfeng capsule (XFC)
Number of subjects: 68
Study: 19346990

Group type: EXPERIMENTAL
Intervention: Physical activity (self-reported using Active Australia questionnaire)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SF-36 physical component summary scores
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: SF-36 physical functioning measures
Number of subjects: 120
Study: 17588706

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 15361940

Group type: EXPERIMENTAL
Intervention: Gabexate mesilate (GM) at 1 mg/kg/hour for 5 days or longer
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (not treated with GM)
Number of subjects: 50
Study: 11738121

Group type: EXPERIMENTAL
Intervention: Antiretroviral treatments
Number of subjects: 0

Group type: COMPARATOR
Intervention: Change of HIV‐1 RNA at the end of follow‐up
Number of subjects: 0

Group type: COMPARATOR
Intervention: HIV‐1 RNA area‐under‐the‐curve during follow‐up minus baseline
Number of subjects: 0
Study: 9673806

Group type: EXPERIMENTAL
Intervention: Physical Therapy (PT) as an adjunct treatment
Number of subjects: 11

Group type: COMPARATOR
Intervention: Relaxation Training/Thermal Biofeedback (RTB)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Physical Therapy (PT) alone
Number of subjects: 11
Study: 7991725

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 3149884

Group type: EXPERIMENTAL
Intervention: Topical mupirocin (3 daily applications for 8 days)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Oral erythromycin ethylsuccinate (40 mg/kg/day divided into four doses for 8 days)
Number of subjects: 62
Study: 30779821

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone (DBB)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Cortical mineralized allogeneic bone (MAB)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Comparison between DBB and MAB
Number of subjects: 17
Study: 28604251

Group type: EXPERIMENTAL
Intervention: Vegetarian diet (V)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional anti-diabetic diet (C)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 74
Study: 25515106

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I) - single 60-70 minute session with self-help pamphlet (n = 20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Wait list control group (n = 20)
Number of subjects: 40
Study: 25623312

Group type: EXPERIMENTAL
Intervention: Pectin (24 g/d for 4 weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 80
Study: 20842375

Group type: EXPERIMENTAL
Intervention: ActiGraph prediction models
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Actical models
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: RT3 proprietary models
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: All prediction models for ADLs
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Seven equations for TRD activities
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Four equations for TRD activities
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Prediction equations overall
Number of subjects: 277
Study: 18358071

Group type: EXPERIMENTAL
Intervention: 300 mg/day SDG
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 600 mg/day SDG
Number of subjects: 87

Group type: COMPARATOR
Intervention: 0 mg/day SDG (placebo)
Number of subjects: 87
Study: 17302251

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted low-dose indinavir (200 mg twice daily) and lamivudine (150 mg twice daily)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted low-dose indinavir and lamivudine
Number of subjects: 26
Study: 12957192

Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: abdomen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: thigh
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily) at injection site: arm
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Enfuvirtide (90 mg twice daily)
Number of subjects: 12
Study: 10711924

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional haemorrhoidectomy
Number of subjects: 22
Study: 9437183

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily equivalent to 0.91 g n‐3 VLCPUFA)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Sunflower oil (placebo)
Number of subjects: 47
Study: 1312078

Group type: EXPERIMENTAL
Intervention: WR‐2721 and radiation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Radiation only
Number of subjects: 100
Study: 4036847

Group type: EXPERIMENTAL
Intervention: 500 mg cholesterol daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 750 mg cholesterol daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1000 mg cholesterol daily
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 500 mg cholesterol daily (healthy women)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 1000 mg cholesterol daily (healthy women)
Number of subjects: 19
Study: 31935197

Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 29773827

Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 19

Group type: COMPARATOR
Intervention: metoprolol
Number of subjects: 19

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 19
Study: 26707946

Group type: EXPERIMENTAL
Intervention: Collaborative Case Conceptualisation (CCC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standardised assessment condition (assessment as usual; AAU)
Number of subjects: 32
Study: 24392774

Group type: EXPERIMENTAL
Intervention: WUP 3 ([(AT-LT)/2] above AT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: WUP 1 ([(AT-LT)/2] below LT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: WUP 2 (midway between LT and AT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: No WUP
Number of subjects: 11
Study: 22772929

Group type: EXPERIMENTAL
Intervention: Depressed learners (minimal, mild, severe depression)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Non-depressed learners
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 222
Study: 20977087

Group type: EXPERIMENTAL
Intervention: RMK (0.25% ropivacaine, morphine 0.2 mg/mL, ketorolac 1 mg/mL)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: RMK
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 26
Study: 17662749

Group type: EXPERIMENTAL
Intervention: Fatigue
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 151

Group type: COMPARATOR
Intervention: Physical functioning and work status
Number of subjects: 151
Study: 16049118

Group type: EXPERIMENTAL
Intervention: Loving-kindness meditation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 43
Study: 12358160

Group type: EXPERIMENTAL
Intervention: Carbamazepine (400 mg) - Test formulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Carbamazepine (400 mg) - Reference formulation
Number of subjects: 24
Study: 10427482

Group type: EXPERIMENTAL
Intervention: Monophasic levonorgestrel (LNG) 100 micrograms/ethinylestradiol (EE) 20 micrograms
Number of subjects: 384
Study: 7488279

Group type: EXPERIMENTAL
Intervention: CAMPATH‐1H (1, 3, 10, 30, 60, and 100 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CAMPATH‐1H
Number of subjects: 40
Study: 2297656

Group type: EXPERIMENTAL
Intervention: 6-hour continuous infusion of doxorubicin
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard rapid infusion of doxorubicin (15 to 20 minutes)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard rapid infusion of doxorubicin
Number of subjects: 62
Study: 7348120

Group type: EXPERIMENTAL
Intervention: Pentazocine (1 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nalorphine (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naloxone (0.4 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No opiate antagonists
Number of subjects: 0
Study: 31856666

Group type: EXPERIMENTAL
Intervention: RNAknot
Number of subjects: 131

Group type: COMPARATOR
Intervention: Vs_subopt, CyloFold, IPknot, Kinefold, RNAstructure, Sfold
Number of subjects: 131
Study: 28110255

Group type: EXPERIMENTAL
Intervention: Standardized patients in psychiatric cases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25865087

Group type: EXPERIMENTAL
Intervention: Combined diabetes specialist/mental health team approach
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 58
Study: 23708746

Group type: EXPERIMENTAL
Intervention: Gabapentin generic formulations (three generic formulations)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Branded formulation of gabapentin
Number of subjects: 24
Study: 21062906

Group type: EXPERIMENTAL
Intervention: Lifestyle modifications (dietary restriction and exercise)
Number of subjects: 57000000

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 57000000

Group type: EXPERIMENTAL
Intervention: Certain medications
Number of subjects: 57000000
Study: 19463392

Group type: EXPERIMENTAL
Intervention: Myoblast transplantation using the Biosense‐NOGA 3‐dimensional‐guided endomyocardial delivery system
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no myoblast transplantation)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Myoblast transplantation
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 23
Study: 17244243

Group type: EXPERIMENTAL
Intervention: 1 unit/ml of heparin saline
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: 10 units/ml of heparin saline
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Normal saline
Number of subjects: 123
Study: 15062883

Group type: EXPERIMENTAL
Intervention: African Americans
Number of subjects: 2727

Group type: COMPARATOR
Intervention: Whites
Number of subjects: 2727
Study: 12647460

Group type: EXPERIMENTAL
Intervention: Day hospital treatment for acute psychiatric patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional inpatient hospital care
Number of subjects: 0
Study: 9640147

Group type: EXPERIMENTAL
Intervention: von Langenbeck palatoplasty
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: push‐back palatoplasty
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: combined push‐back palatoplasty and superior pharyngeal flap surgery
Number of subjects: 312
Study: 8605897

Group type: EXPERIMENTAL
Intervention: Ceftriaxone 1 g/day
Number of subjects: 222

Group type: COMPARATOR
Intervention: Ceftriaxone 2 g/day
Number of subjects: 222
Study: 2665059

Group type: EXPERIMENTAL
Intervention: Insulin treatment (25 U fast-acting insulin bolus followed by continuous infusion of 1 U/kg b.w. for 1 hour)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no insulin treatment)
Number of subjects: 17
Study: 793766

Group type: EXPERIMENTAL
Intervention: Acidulated phosphate fluoride (APF 1.23%)
Number of subjects: 1653

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1653
Study: 31078180

Group type: EXPERIMENTAL
Intervention: Transcatheter edge‐to‐edge repair (MitraClip)
Number of subjects: 0
Study: 28898239

Group type: EXPERIMENTAL
Intervention: Counselling for Alcohol Problems (CAP) plus enhanced usual care (EUC)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC) alone
Number of subjects: 377
Study: 25562591

Group type: EXPERIMENTAL
Intervention: Clinician-rated CGI-S
Number of subjects: 1010

Group type: EXPERIMENTAL
Intervention: Patient-rated CGI-S
Number of subjects: 1010
Study: 23709323

Group type: EXPERIMENTAL
Intervention: Crushed MSN (≥60/2.4 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Intact MSN
Number of subjects: 14
Study: 21733166

Group type: EXPERIMENTAL
Intervention: Invasive urodynamic testing (IUT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic clinical assessment with non-invasive tests
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative interviews of women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: National survey of clinicians
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative interviews of clinicians
Number of subjects: 0
Study: 19784374

Group type: COMPARATOR
Intervention: SP+AQ
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: DHA+PQ
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: SP+PQ
Number of subjects: 1893

Group type: EXPERIMENTAL
Intervention: Piperaquine combinations
Number of subjects: 1893
Study: 17113894

Group type: EXPERIMENTAL
Intervention: BPS‐1
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: BPS‐2
Number of subjects: 55
Study: 15311654

Group type: EXPERIMENTAL
Intervention: Stimulus intensity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manual responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saccadic responses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exogenous saccades
Number of subjects: 0
Study: 11104595

Group type: EXPERIMENTAL
Intervention: Standard preoperative and postoperative tube-feeding (group II)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Arginine-supplemented preoperative and postoperative tube-feeding (group III)
Number of subjects: 49

Group type: COMPARATOR
Intervention: No preoperative and standard postoperative tube-feeding (group I)
Number of subjects: 49
Study: 9301462

Group type: EXPERIMENTAL
Intervention: Amifostine (910 mg/m2) before cyclophosphamide (1500 mg/m2) for two cycles
Number of subjects: 40

Group type: COMPARATOR
Intervention: Amifostine/cyclophosphamide only on one cycle (patients were their own control)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cyclophosphamide alone without amifostine protection
Number of subjects: 40
Study: 8281220

Group type: EXPERIMENTAL
Intervention: Low-calorie
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-fat
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 3434998

Group type: EXPERIMENTAL
Intervention: Standardized aggressive treatment including wide resection, adjuvant radio- or chemotherapy and management of advanced disease
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation followed by surgery
Number of subjects: 304

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Adjuvant cytostatic therapy in patients with colonic tumours of Dukes B and C stages
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Irradiation followed by attempted curative surgery in primarily inoperable rectal cancer
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Right hemicolectomy
Number of subjects: 304
Study: 29938604

Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 14
Study: 23579581

Group type: EXPERIMENTAL
Intervention: Pudendal nerve stimulation (PNS) for constipation predominant patients (group 1)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Pudendal nerve stimulation (PNS) for incontinence predominant patients (group 2)
Number of subjects: 13
Study: 22924756

Group type: EXPERIMENTAL
Intervention: sodium fluoride/triclosan/copolymer (TCN/C)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: stannous fluoride/sodium hexametaphosphate/zinc lactate (SnF(2)/SHMP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: sodium fluoride (NaF)
Number of subjects: 35